The 781 Hemp Rule Is a Wake-Up Call for Payment Processors and Banks Why Product-Level Intelligence Is Becoming the New Standard for Merchant Risk For the past several years, the hemp industry has operated in one of the most complex and rapidly evolving regulatory environments in commerce. Federal guidance, state laws, card brand policies, and […]
The hemp and CBD industry entered full panic mode last month. A restrictive provision slipped into the government spending bill threatened to wipe out an estimated 95% of the hemp market overnight. Now, Trump's executive order is signaling a course correction, and potentially paving the way for hemp CBD banking reform that could reshape the […]
"This marks the most significant federal policy on this in more than five decades." — Brian Fitzpatrick, CEO of Qredible Subscribe to Qredible Live About This Episode On December 18th, President Trump signed an executive order directing the rescheduling of cannabis from Schedule 1 to Schedule 3—a move that has generated both excitement and confusion […]
Pennsylvania House Democrats have introduced legislation establishing comprehensive kratom regulation following Ohio's recent synthetic kratom ban and growing concerns about unregulated products reaching children. House Bill 2058, introduced by Reps. Emily Kinkead and Jim Prokopiak, would prohibit kratom sales to individuals under 21, ban synthetic kratom products entirely, require testing and clear labeling including ingredients […]
Missouri Attorney General Catherine Hanaway has expanded her statewide investigation into manufacturers and businesses selling kratom and synthetic 7-OH products, issuing Civil Investigative Demands to nine retailers following "troubling reports that consumers may be exposed to unapproved, unsafe and deceptively marketed opioid-like drugs." The investigation, which began with six CIDs issued in late November, includes […]
Ohio Governor Mike DeWine signed an executive order making synthetic kratom illegal following a unanimous Ohio Board of Pharmacy vote to ban the sale, purchase, possession, and use of synthetic kratom products. The pharmacy board cited the substance's potency, potential for abuse, opioid-like characteristics, and links to overdose deaths as justification for immediate regulatory action, […]
The Creatine Global initiative's regulatory framework aims at establishing legislation and regulatory standards for creatine fortification to provide adequate information enabling informed consumer choice, prevent misleading or deceptive behaviors, and enable fair trade toward protection of public health. This comprehensive approach to ingredient regulation offers valuable lessons for supplement manufacturers navigating complex compliance requirements across […]
The FDA published final guidance Monday to assist sponsors in identifying appropriate supplement categories for biosimilar prior approval supplements, establishing clear review timelines and creating consistent evaluation standards. The guidance specifies six types of prior approval supplement categories under the Biosimilar User Fee Amendments of 2022, fulfilling a commitment outlined in the BsUFA III commitment […]
The beauty supplements market is estimated at $3.96 billion in 2025 and projected to reach $5.76 billion by 2030, representing a compound annual growth rate of 7.8% according to research from MarketsandMarkets. This robust growth is underpinned by increasing consumer concern for skin, hair, and overall health, with growing affinity for natural and plant-based products […]
Fraud in B2B payments has evolved from occasional operational disruptions into a persistent, adaptive threat that poses existential risks to businesses processing high-value transactions. The reason is straightforward: with transaction volumes and values dwarfing consumer payments, B2B commerce represents an irresistible target for sophisticated fraudsters whose tactics evolve as rapidly as digital commerce itself. "B2B […]
